Award
National Cancer Institute 5R01CA195524-10
Early Detection of Hepatocellular Carcinoma
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$663,280.00
Ceiling
$663,280.00
Awarded
February 26, 2026
Identifier
5R01CA195524-10
Award for research on early detection of hepatocellular carcinoma using blood and imaging modalities, including AI-based analysis and biomarker identification, funded by NIH for $663,280.
Description
This NIH project focuses on developing blood-based and imaging-based modalities for early detection and risk stratification of hepatocellular carcinoma (HCC). The project involves longitudinal collection of blood samples and MRIs, development of AI-based imaging analysis tools, and identification of biomarkers for early detection. The project is funded for the fiscal year 2026 with a total award amount of $663,280.